Neoadjuvant chemotherapy alone with mFOLFOXIRI in locally advanced rectal cancer: A single-arm phase II study.

被引:0
|
作者
Deng, Yanhong [1 ]
Zhang, Jianwei [1 ]
Cai, Yue [1 ]
Hu, Huabin [1 ]
Ling, Jiayu [1 ]
Xiao, Jian [1 ]
Huang, Meijin [1 ]
Kang, Liang [1 ]
Wang, Lei [1 ]
Lan, Ping [1 ]
Wang, Jianping [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China
关键词
D O I
10.1200/jco.2016.34.4_suppl.tps783
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS783
引用
收藏
页数:1
相关论文
共 50 条
  • [31] A multicenter phase II study on the feasibility and efficacy of neoadjuvant chemotherapy for locally advanced rectal cancer.
    Goto, Saori
    Hasegawa, Suguru
    Matsumoto, Takuya
    Hida, Koya
    Kawamura, Junichiro
    Yamanokuchi, Satoshi
    Yamaguchi, Takashi
    Matsusue, Ryo
    Kadokawa, Yoshio
    Kato, Shigeru
    Manaka, Dai
    Nishitai, Ryuta
    Nomura, Akinari
    Kanazawa, Akiyoshi
    Kawada, Kenji
    Kyogoku, Takahisa
    Sakai, Yoshiharu
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [32] Prospective single-arm study of intraoperative radiotherapy for locally advanced or recurrent rectal cancer
    Tan, Jennifer
    Heriot, Alexander G.
    Mackay, Jack
    Van Dyk, Sylvia
    Bressel, Mathias A. B.
    Fox, Chris D.
    Hui, Andrew C.
    Lynch, A. Craig
    Leong, Trevor
    Ngan, Samuel Y.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2013, 57 (05) : 617 - 625
  • [33] Camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (ESCC): A single-arm, phase II trial
    Gong, Lei
    Yang, Yueyang
    Zhang, Hongdian
    Qiao, Yufeng
    Wang, Haitong
    Ren, Peng
    Tang, Peng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: A single-arm, phase II trial
    Wu, Wenjie
    Yao, Jie
    Zhang, Tong
    Zhang, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
    Liu, Jun
    Yang, Yang
    Liu, Zhichao
    Fu, Xiaolong
    Cai, Xiaoyue
    Li, Hongxuan
    Zhu, Li
    Shen, Yan
    Zhang, Hong
    Sun, Yifeng
    Chen, Hezhong
    Yu, Bentong
    Zhang, Renquan
    Shao, Jinchen
    Zhang, Ming
    Li, Zhigang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
  • [36] Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer: A single center phase II trial.
    Zhang Wen
    Zhou Haitao
    Jiang Jun
    Zhu Yuelu
    Zou Shuangmei
    Tang Yuan
    Liang Jianwei
    Sun Yongkun
    Jiang Zhichao
    Zhou Zhixiang
    Zhou Aiping
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [37] Neoadjuvant camrelizumab followed by concurrent camrelizumab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, phase II study
    Sheng, Yinliang
    Meng, Xiangrui
    Zhang, Chunyang
    Shan, Zhengzheng
    Li, Feng
    Wu, Bin
    Xu, Mengli
    Li, Aijia
    Guan, Lulu
    Chen, Lidong
    Sun, Shuzhen
    Ma, Yihui
    Lu, Taiying
    Zhao, Song
    Fan, Qingxia
    Qi, Yu
    Wang, Feng
    JOURNAL OF THORACIC DISEASE, 2024, 16 (08) : 5337 - 5347
  • [38] The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial
    Huang, Nai-si
    Wei, Wen-jun
    Xiang, Jun
    Chen, Jia-ying
    Guan, Qing
    Lu, Zhong-wu
    Ma, Ben
    Sun, Guo-hua
    Wang, Yu-long
    Ji, Qing-hai
    Wang, Yu
    THYROID, 2021, 31 (12) : 1808 - 1813
  • [39] Neoadjuvant chemotherapy for locally advanced rectal cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (10): : 876 - 876
  • [40] Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
    Papaccio, Federica
    Rosello, Susana
    Huerta, Marisol
    Gambardella, Valentina
    Tarazona, Noelia
    Fleitas, Tania
    Roda, Desamparados
    Cervantes, Andres
    CANCERS, 2020, 12 (12) : 1 - 12